ClinicalTrials.Veeva

Menu

Long COVID and Its Associations With Health Outcomes in Older Adults

P

Peking University

Status

Active, not recruiting

Conditions

Reinfection
Long COVID
Vaccine Reaction
Lifestyle Factors
Elderly Infection
COVID-19 Pandemic

Treatments

Other: no interventions

Study type

Observational

Funder types

Other

Identifiers

NCT05825651
NNSF72211540398

Details and patient eligibility

About

The Peking University Health Cohort in Anning, Yunnan (PKUHC-AN) is a prospective cohort study carried out in Anning, Yunnan. The primary aim of this study is to investigate the impact of COVID-19 on older adults' health, and to provide high-quality evidence of real world research for the optimization of prevention and control strategies of COVID-19 and other emerging infectious diseases. Data will be collected regarding health status, history of COVID-19 infections and vaccines, lifestyle and socioeconomic characteristics, as well as the short- and long-term health outcomes.

Full description

COVID-19 pandemic attributed to a great number of mortalities around the world in the last 3 years. About 46% of the global population are estimated to have been infected by the omicron variant and its sublineages. Health outcomes post COVID-19 has been of great concern globally since more and more people infected by SARS-CoV-2. Integrated efforts should be made to estimate the incidence of reinfections and long COVID in China, especially among older adults who are vunlerable and susceptible to COVID-19. In view of this, the Peking University Health Cohort Study in Anning, Yunnan aims to investigate the impact of COVID-19 on older adults' health, and to provide high-quality evidence of real world research for the optimization of prevention and control strategies of COVID-19 and other emerging infectious diseases. Data will be collected regarding health status, history of COVID-19 infections and vaccines, lifestyle and socioeconomic characteristics, as well as the short- and long-term health outcomes.

Enrollment

11,527 patients

Sex

All

Ages

60+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

    1. ≥60 years
    1. Resided in Anning in the past half year and have no plan to move out in next 1 year
    1. Older adults who are willing to participate in this study with informed consent

Exclusion criteria

    1. Unable to answer questions or communicate
    1. Older adults who are not willing to participate in this study or without informed consent

Trial design

11,527 participants in 2 patient groups

Exposure group
Description:
Group with history of COVID-19 infections and vaccines, as well as health-related, behavioral, socioeconomic exposures.
Treatment:
Other: no interventions
Non-exposure group
Description:
Group without history of COVID-19 infections and vaccines, as well as health-related, behavioral, socioeconomic exposures.

Trial contacts and locations

1

Loading...

Central trial contact

Jue Liu, Ph.D; Yaping Wang, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems